Opna Bio Announces 2024 ASH Presentations Highlighting Interim Data from Phase 1 Combo Study of BET Inhibitor OPN-2853 with Ruxolitinib in Myelofibrosis, and Promising Preclinical Data with EP300CBP Bromodomain Inhibitor OPN-6602 in Multiple Myeloma
| ATRFX Fund | USD 11.85 0.08 0.68% |
Slightly above 52% of Catalyst Intelligent's investor base is interested to short. The analysis of overall sentiment of trading Catalyst Intelligent Alternative mutual fund suggests that many investors are impartial at this time. Catalyst Intelligent's investing sentiment can be driven by a variety of factors including economic data, Catalyst Intelligent's earnings reports, geopolitical events, and overall market trends.
Catalyst |
Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that two
Read at businesswire.com
 |
Catalyst Intelligent Fundamental Analysis
We analyze Catalyst Intelligent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalyst Intelligent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalyst Intelligent based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Equity Positions Weight
Equity Positions Weight Comparative Analysis
Catalyst Intelligent is currently under evaluation in equity positions weight among similar funds. Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
Catalyst Intelligent Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Catalyst Intelligent mutual fund to make a market-neutral strategy. Peer analysis of Catalyst Intelligent could also be used in its relative valuation, which is a method of valuing Catalyst Intelligent by comparing valuation metrics with similar companies.
Peers
Catalyst Intelligent Related Equities
| FZABX | Fidelity Advisor | 0.72 | ||||
| RTOUX | Tax-managed | 0.18 | ||||
| GABSX | The Gabelli | 0.15 | ||||
| FTHNX | Fuller Thaler | 0.36 | ||||
| WMCVX | Wasatch Small | 0.40 | ||||
| PASVX | T Rowe | 0.55 | ||||
| NSIDX | Northern Small | 0.68 |
Other Information on Investing in Catalyst Mutual Fund
Catalyst Intelligent financial ratios help investors to determine whether Catalyst Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Catalyst with respect to the benefits of owning Catalyst Intelligent security.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |